Home › Shire faces tougher task playing defence than AstraZeneca
 

Keywords :   


Shire faces tougher task playing defence than AstraZeneca

2014-06-19 10:28:04| Biotech - Topix.net

Drug maker Shire's $35-billion market cap puts it within the sights of a wider range of possible acquirers, such as Amgen or Bristol-Myers Squibb, whereas rival Astra failed to attract another suitor.

Tags: playing task faces defence

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
18.06Potential Tropical Cyclone One Graphics
18.06Potential Tropical Cyclone One Public Advisory Number 4A
18.06Summary for Potential Tropical Cyclone One (AT1/AL012024)
18.06Atlantic Tropical Weather Outlook
18.06Eastern North Pacific Tropical Weather Outlook
18.06CCAI Recognizes 2024 Award Recipients
18.06German court dismisses anti-competitive claims against Tageos
18.06A Request From the A League of Their Own Womens Special Interest Group
More »